- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Recursion Pharmaceuticals Inc (RXRX)
Assess today's live Recursion Pharmaceuticals Inc (RXRX) share price, performance and insights using our live NASDAQ: RXRX stock exchange data.
Analyse the historical data and Recursion Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Recursion Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Recursion Pharmaceuticals (RXRX) stock price today with other investors in the Recursion Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ RXRX share price (ISIN: US75629V1044) to enhance your trading decisions with our free investment tools and resources.
What Is the Recursion Pharmaceuticals Inc Share Price Today?
The Recursion Pharmaceuticals share price today is 3.44.
What Is the Stock Symbol for Recursion Pharmaceuticals Inc
The stock symbol (or 'ticker') for Recursion Pharmaceuticals Inc is "RXRX."
What Stock Exchange Does Recursion Pharmaceuticals Inc Trade On?
Recursion Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Recursion Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Recursion Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Recursion Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Recursion Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Recursion Pharmaceuticals (RXRX) stock price today with other investors in the Recursion Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ RXRX share price (ISIN: US75629V1044) to enhance your trading decisions with our free investment tools and resources.
What Is the Recursion Pharmaceuticals Inc Share Price Today?
The Recursion Pharmaceuticals share price today is 3.44.
What Is the Stock Symbol for Recursion Pharmaceuticals Inc
The stock symbol (or 'ticker') for Recursion Pharmaceuticals Inc is "RXRX."
What Stock Exchange Does Recursion Pharmaceuticals Inc Trade On?
Recursion Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Recursion Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Recursion Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.14
3.44
52 wk Range
2.80
7.18
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.143.44
52 wk Range
2.807.18
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RXRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
6.57
Upside
+91.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form DEF 14A Recursion Pharmaceuticals For: 30 April
- Investing.com
- Form 10Q Recursion Pharmaceuticals Inc For: 6 May
- Investing.com
- Form 10Q Recursion Pharmaceuticals Inc For: 6 May
- Investing.com
- Form 144 RECURSION PHARMACEUTICALS For: 5 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
5 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.57
(+91.03% Upside)
Recursion Pharmaceuticals Inc Earnings Call Summary for Q1/2026
- Q1 2026 EPS of -$0.22 beat estimates by 15.38%, but revenue of $6.47M missed forecasts by 60.26%, triggering a 5.34% pre-market stock decline to $3.19.
- Company achieved 30% year-over-year reduction in operating expenses while maintaining $665M cash position, extending operational runway through early 2028.
- Q2 2026 guidance projects EPS of -$0.24 with $17.3M revenue; Q3 forecasts -$0.23 EPS with $22.6M revenue as management focuses on cost discipline.
- Management emphasized multiple clinical milestones expected over next 18 months, though significant Q1 revenue shortfall raised investor concerns about growth trajectory.
Last Updated: 06/05/2026, 14:34
Read Full TranscriptEarnings
Latest Release
06/05/2026
EPS / Forecast
-0.22 / -0.26
Revenue / Forecast
6.47M / 16.28M
Compare RXRX to Peers and Sector
Metrics to compare | RXRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRXRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | −7.2x | −0.5x | |
PEG Ratio | −0.19 | −0.14 | 0.00 | |
Price/Book | 1.6x | 2.7x | 2.6x | |
Price / LTM Sales | 24.3x | 24.3x | 3.2x | |
Upside (Analyst Target) | 76.5% | 76.4% | 47.8% | |
Fair Value Upside | Unlock | −15.3% | 5.9% | Unlock |
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Recursion Pharmaceuticals (NASDAQ: RXRX) Share Price Today?
The Recursion Pharmaceuticals stock price today is 3.44 USD.
What Stock Exchange Does Recursion Pharmaceuticals (RXRX) Trade On?
Recursion Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Recursion Pharmaceuticals?
The stock symbol (also called a 'ticker') for Recursion Pharmaceuticals is "RXRX."
What Is the Current Recursion Pharmaceuticals Market Capitalisation?
As of today, Recursion Pharmaceuticals (NASDAQ: RXRX) market cap is 1.81B USD.
What Is Recursion Pharmaceuticals's (RXRX) Earnings Per Share (TTM)?
The Recursion Pharmaceuticals EPS is currently -1.44 (Trailing Twelve Months).
When Is the Next Recursion Pharmaceuticals Earnings Date?
Recursion Pharmaceuticals's next earnings report will be released on 06/05/2026.
Is RXRX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Recursion Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for RXRX stock is Strong Sell.
How Many Times Has Recursion Pharmaceuticals Stock Split?
Recursion Pharmaceuticals has split 0 times. (See the RXRX stock split history page for full effective split date and price information.)
How Many Employees Does Recursion Pharmaceuticals Have?
Recursion Pharmaceuticals has 600 employees, based on their latest Companies House report.
What is the current trading status of Recursion Pharmaceuticals (NASDAQ: RXRX)?
As of 06/05/2026, Recursion Pharmaceuticals (RXRX) is trading at a share price of 3.44 USD, with a previous close of 3.37 USD. The stock has fluctuated within a day range of 3.14 USD to 3.44 USD, while its 52-week range spans from 2.80 USD to 7.18 USD.
What Is Recursion Pharmaceuticals (RXRX) Price Target According to Analysts?
The average 12-month price target for Recursion Pharmaceuticals is 6.57 USD, with a high estimate of 10 USD and a low estimate of 3 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +91.03% Upside potential.
What Is the RXRX Premarket Price?
RXRX's last pre-market stock price is 3.19 USD. The pre-market share volume is 2,570,000.00, and the stock has decreased by -0.18, or -5.34%.
What Is the RXRX After Hours Price?
RXRX's last after hours stock price is 3.36 USD, the stock has decreased by -0.07, or -2.04%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.